Use of 17-oxyprogesterone-capronate in genital endometriosis

Among the existing treatments for endometriosis patients, hormone therapy has attracted particular attention in recent years. Experimental and clinical observations have established that the growth and development of endometroid heterotopias occurs against a background of hormonal imbalance in the female body. An increased secretion of oestrogenic hormones and an insufficient function of corpus luteum hormone play a major role.